Botanix Pharmaceuticals Ltd
ASX:BOT
Australia / Healthcare / Pharmaceuticals
Exchange Data
Hide this widget
Price
0.40 AUD
Day change
0.01 (2.60%)
52-week range
0.21 - 0.54
2:04 PM - Closed
Summary of Botanix Pharmaceuticals Ltd
Hide this widget
Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia and the United States. ...
Latest Report
Aug 30, 2024Next Earnings
May 26, 2025
Price History
Chart Gallery
Hide this widget
1 Week
1 Month
3 Months
1 Year
5 Year
10 Years
-0.02 (-4.82%)
Data Explorer
Hide this widget
Search metric that you want to observe. Create your own widget, customise and rearrange metrics
| Metric Name | Value | Trend |
|---|---|---|
| Dividend Yield | 0.0% | |
| P/E Ratio | -18.4x | |
| Revenue | 2.069 M | |
| Net Income to Company | -39.291 M |
Peer Benchmarks
Hide this widget
Quote
Value
Size
Growth
Profit
| BOT | Peers | Sector | |
|---|---|---|---|
Market Cap | 723.9 M | 33.642 M | 100.1 M |
Price % of 52 Week High | 73.8% | 47.9% | 60.1% |
Dividend Yield | 0.0% | 0.0% | 0.0% |
Shareholder Yield | -10.2% | -19.2% | -0.7% |
1 Year Price Total Return | 75.6% | -25.7% | -12.6% |
Beta (5 Year) | 1.27 | 0.94 | 0.64 |
In the News
Hide this widget
Fair Value
Hide this widget
Average
–
Upside
–
Uncertainty
–
Spread
–
Financial Health
Health Details
Hide this widget
Financial Health for Botanix Pharma is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.
12345
Financial Models for Botanix Pharmaceuticals Ltd
Model Gallery
Hide this widget
| 5Y DCF Growth ExitView Updated 8 hours ago |
| DuPont ROE AnalysisView Updated 3 minutes ago |
| 10Y Historical FinancialsView Updated 3 minutes ago |
| 5Y Historical FinancialsView Updated 3 minutes ago |
| EV / EBIT MultiplesView Updated 8 hours ago |
| EV / EBITDA MultiplesView Updated 8 hours ago |
| P/E MultiplesView Updated 8 hours ago |
| Price / Book MultiplesView Updated 8 hours ago |
| Price / Sales MultiplesView Updated 8 hours ago |
| EV / Revenue MultiplesView Updated 8 hours ago |
| CAPM WACC ModelView Updated 14 hours ago |
| 10Y DCF EBITDA ExitView Updated 8 hours ago |
| 10Y DCF Revenue ExitView Updated 8 hours ago |
| 10Y DCF Growth ExitView Updated 8 hours ago |
| 5Y DCF EBITDA ExitView Updated 8 hours ago |
| 5Y DCF Revenue ExitView Updated 8 hours ago |
| Earnings Power ValueView Updated 8 hours ago |
Historical Financials
Full Financials
Hide this widget
| (AUD in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Jun-23 | Jun-24 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 3.77 | 2.07 | 2.07 | 0.19 | 0.19 |
| Operating Income | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Net Profit | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Diluted EPS | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| EBITDA | (9.11) | (14) | (39) | (2.76) | (15) |
| Balance Sheet | |||||
| Cash & ST Invest. | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Equity | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Debt | 0.00 | 0.00 | 0.87 | 0.00 | 0.87 |
| Cash Flow Statement | |||||
| Cash Flow Operations | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Investing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Financing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Free Cash Flow | (12) | (8.24) | (35) | (1.90) | (15) |
Analyst Notes
April 19, 2025
Hide this widget